Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens.

Liu J, Babaian DC, Liebert M, Steck PA, Kagan J.

Mol Carcinog. 2000 Nov;29(3):143-50.

PMID:
11108659
2.

MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.

Tanaka M, Koul D, Davies MA, Liebert M, Steck PA, Grossman HB.

Oncogene. 2000 Nov 9;19(47):5406-12.

3.

Transforming growth factor-alpha antisense vectors can inhibit glioma cell growth.

Tang P, Jasser SA, Sung JC, Shi Y, Steck PA, Yung WK.

J Neurooncol. 1999 Jun;43(2):127-35.

PMID:
10533724
4.

Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.

Davies MA, Koul D, Dhesi H, Berman R, McDonnell TJ, McConkey D, Yung WK, Steck PA.

Cancer Res. 1999 Jun 1;59(11):2551-6.

5.

Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis.

Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong YK, Yung WK, Steck PA.

Cancer Res. 1999 Apr 15;59(8):1820-4.

6.

Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.

Im SA, Gomez-Manzano C, Fueyo J, Liu TJ, Ke LD, Kim JS, Lee HY, Steck PA, Kyritsis AP, Yung WK.

Cancer Res. 1999 Feb 15;59(4):895-900.

7.

Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase.

Morimoto AM, Berson AE, Fujii GH, Teng DH, Tavtigian SV, Bookstein R, Steck PA, Bolen JB.

Oncogene. 1999 Feb 11;18(6):1261-6.

8.

Functional and molecular analyses of 10q deletions in human gliomas.

Steck PA, Lin H, Langford LA, Jasser SA, Koul D, Yung WK, Pershouse MA.

Genes Chromosomes Cancer. 1999 Feb;24(2):135-43.

PMID:
9885980
9.

Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.

Davies MA, Lu Y, Sano T, Fang X, Tang P, LaPushin R, Koul D, Bookstein R, Stokoe D, Yung WK, Mills GB, Steck PA.

Cancer Res. 1998 Dec 1;58(23):5285-90. Erratum in: Cancer Res 1999 Mar 1;59(5):1167.

10.

Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.

Lin H, Bondy ML, Langford LA, Hess KR, Delclos GL, Wu X, Chan W, Pershouse MA, Yung WK, Steck PA.

Clin Cancer Res. 1998 Oct;4(10):2447-54.

11.

A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes.

Ke LD, Fueyo J, Chen X, Steck PA, Shi YX, Im SA, Yung WK.

Int J Oncol. 1998 Jun;12(6):1391-6.

PMID:
9592205
12.

Differentially expressed gene products in glioblastoma cells suppressed for tumorigenicity.

Ligon AH, Pershouse MA, Jasser S, Hong YK, Yung WK, Steck PA.

J Neurovirol. 1998 Apr;4(2):217-26.

PMID:
9584958
13.

The autocrine loop of TGF-alpha/EGFR and brain tumors.

Tang P, Steck PA, Yung WK.

J Neurooncol. 1997 Dec;35(3):303-14. Review.

PMID:
9440027
14.

MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA, et al.

Cancer Res. 1997 Dec 1;57(23):5221-5.

15.

Suppression of transformed phenotype and tumorigenicity after transfer of chromosome 4 into U251 human glioma cells.

Pershouse MA, Ligon AH, Pereira-Smith OM, Killary AM, Yung WK, Steck PA.

Genes Chromosomes Cancer. 1997 Nov;20(3):260-7.

PMID:
9365833
16.

Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis.

Gomez-Manzano C, Fueyo J, Kyritsis AP, McDonnell TJ, Steck PA, Levin VA, Yung WK.

J Natl Cancer Inst. 1997 Jul 16;89(14):1036-44.

PMID:
9230885
17.

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV.

Nat Genet. 1997 Apr;15(4):356-62.

PMID:
9090379
18.

Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma.

Ligon AH, Pershouse MA, Jasser SA, Yung WK, Steck PA.

Oncogene. 1997 Mar 6;14(9):1075-81.

19.

Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma.

Pershouse MA, El-Naggar AK, Hurr K, Lin H, Yung WK, Steck PA.

Oncogene. 1997 Jan 23;14(3):369-73.

20.

Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.

Hsu SC, Volpert OV, Steck PA, Mikkelsen T, Polverini PJ, Rao S, Chou P, Bouck NP.

Cancer Res. 1996 Dec 15;56(24):5684-91.

21.

Primitive neuroectodermal tumor of the median nerve. Case report with cytogenetic analysis.

Akeyson EW, McCutcheon IE, Pershouse MA, Steck PA, Fuller GN.

J Neurosurg. 1996 Jul;85(1):163-9.

PMID:
8683268
22.

Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis.

Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA, Yung WK.

Cancer Res. 1996 Feb 15;56(4):694-9.

23.

Two tumor suppressive loci on chromosome 10 involved in human glioblastomas.

Steck PA, Ligon AH, Cheong P, Yung WK, Pershouse MA.

Genes Chromosomes Cancer. 1995 Apr;12(4):255-61.

PMID:
7539279
24.

Analysis of the functional role of chromosome 10 loss in human glioblastomas.

Pershouse MA, Stubblefield E, Hadi A, Killary AM, Yung WK, Steck PA.

Cancer Res. 1993 Oct 15;53(20):5043-50.

25.

Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials.

Inoue T, Cavanaugh PG, Steck PA, Brünner N, Nicolson GL.

J Cell Physiol. 1993 Jul;156(1):212-7.

PMID:
8314858
26.

Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R.

Cancer Res. 1993 May 15;53(10 Suppl):2208-11.

27.

Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.

Rao JS, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta LA, Sawaya R.

J Neurooncol. 1994;18(2):129-38. Review.

PMID:
7964975
29.

Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer.

Putnam EA, Yen N, Gallick GE, Steck PA, Fang K, Akpakip B, Gazdar AF, Roth JA.

Surg Oncol. 1992 Feb;1(1):49-60.

PMID:
1341235
30.

Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells.

Kim JS, Steck PA, Gallick GE, Lee JS, Blick M, Hong WK, Lotan R.

J Natl Cancer Inst Monogr. 1992;(13):101-10.

PMID:
1389683
31.

Pathways of oncogenesis in primary brain tumors.

Steck PA, Saya H.

Curr Opin Oncol. 1991 Jun;3(3):476-84. Review.

PMID:
1909900
32.

Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.

Grimm EA, Bruner JM, Carinhas J, Köppen JA, Loudon WG, Owen-Schaub L, Steck PA, Moser RP.

Cancer Immunol Immunother. 1991;32(6):391-9.

PMID:
1848799
33.

Growth regulatory activities of endothelial extracellular matrix: mediation by transforming growth factor-beta.

Newton LK, Yung WK, Pettigrew LC, Steck PA.

Exp Cell Res. 1990 Sep;190(1):127-32.

PMID:
2387324
34.
35.

Inhibition of epidermal growth factor receptor activity by retinoic acid in glioma cells.

Steck PA, Hadi A, Lotan R, Yung WK.

J Cell Biochem. 1990 Feb;42(2):83-94.

PMID:
2307713
36.

Differential amplification of the TGF-alpha gene in human gliomas.

Yung WK, Zhang X, Steck PA, Hung MC.

Cancer Commun. 1990;2(6):201-5.

PMID:
2165797
37.

Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3.

Frazier ML, Pathak S, Wang ZW, Cleary K, Singletary SE, Olive M, Mackay B, Steck PA, Levin B.

Pancreas. 1990;5(1):8-16.

PMID:
1688394
38.
39.

The modulation of astrocytic differentiation in cells derived from a medulloblastoma surgical specimen.

Maria BL, Steck PA, Yung WK, Milici A, Bruner JM, Pathak S, Becker FF.

J Neurooncol. 1989 Nov;7(4):329-38.

PMID:
2555453
40.

Altered expression and distribution of heparan sulfate proteoglycans in human gliomas.

Steck PA, Moser RP, Bruner JM, Liang L, Freidman AN, Hwang TL, Yung WK.

Cancer Res. 1989 Apr 15;49(8):2096-103.

41.

Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells.

Yung WK, Lotan R, Lee P, Lotan D, Steck PA.

Cancer Res. 1989 Feb 15;49(4):1014-9.

42.
43.

Expression of an altered epidermal growth factor receptor by human glioblastoma cells.

Steck PA, Lee P, Hung MC, Yung WK.

Cancer Res. 1988 Oct 1;48(19):5433-9.

44.

In vitro cytolysis of primitive neuroectodermal tumors of the posterior fossa (medulloblastoma) by lymphokine-activated killer cells.

George RE, Loudon WG, Moser RP, Bruner JM, Steck PA, Grimm EA.

J Neurosurg. 1988 Sep;69(3):403-9.

PMID:
3261328
46.

Altered expression of glycosaminoglycans in metastatic 13762NF rat mamma adenocarcinoma cells.

Steck PA, Cheong PH, Nakajima M, Yung WK, Moser RP, Nicolson GL.

Biochemistry. 1987 Feb 24;26(4):1020-8.

PMID:
3567153
47.

Growth inhibitory effect of recombinant alpha and beta interferon on human glioma cells.

Yung WK, Steck PA, Kelleher PJ, Moser RP, Rosenblum MG.

J Neurooncol. 1987;5(4):323-30.

PMID:
2964515
49.

Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells.

Steck PA, Gallick GE, Maxwell SA, Kloetzer WS, Arlinghaus RB, Moser RP, Gutterman JU, Yung WK.

J Cell Biochem. 1986;32(1):1-10.

PMID:
3533968
50.

Head and neck squamous cell carcinoma cell lines as a model system for the study of oncogene expression during tumor progression and metastasis.

Gallick GE, Sacks PG, Maxwell SA, Steck PA, Gutterman JU.

Prog Clin Biol Res. 1986;212:97-111. No abstract available.

PMID:
3012576

Supplemental Content

Loading ...
Support Center